Some of these inhibitors bind STAT5 proteins in a nanomolar range and inhibit the tyrosine phosphorylation of STAT5 and CML/AML cell growth in a micromolar range [15,16,17]. The gene discussed is STAT5A; the disease is acute myeloid leukemia.